Welcome to ATMP Sweden!
ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
The ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu. Other Swedish ATMP specific national networks within the ATMP Sweden umbrella include NextGenNK focused on cost effective development of Natural Killer (NK) cell based therapies and SWECARNET, Sweden’s network for clinical use of CAR T cells.
Work with us towards making Sweden a world leader in advanced therapies by 2030.
Competence Center for the development of next generation NK cell-based cancer immunotherapies.
Conferences & events
Research & development
Learn more about the Health Technology Assessment related issues of your ATMP development.
This guide will provide useful information and insights throughout the ATMP development process.
What are ATMPs?
Inaugural “ATMP world tour” 2021
Driving International dialogue in cell and gene therapyRead article
ATMP SWEDEN NEWSLETTER FEBRUARY 2021
Catch up on the latest including Swedish COVID-19 ATMPs and the ATMP world tour 2021!Read article
SDP1 permits and standards for cellular ATMPs
Donors, manufacture, pharmacy and clinic....what permits are needed by who and from whom? What quality standards?Read article